about
CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activityγδ-T cells: an unpolished sword in human anti-infection immunityDefining the nature of human γδ T cells: a biographical sketch of the highly empatheticHarnessing the power of Vδ2 cells in cancer immunotherapyγδ T cells in cancer immunotherapyTargeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerThe interaction of influenza H5N1 viral hemagglutinin with sialic acid receptors leads to the activation of human γδ T cells.Identification of human T cell receptor gammadelta-recognized epitopes/proteins via CDR3delta peptide-based immunobiochemical strategy.DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritisAltered time structure of neuro-endocrine-immune system function in lung cancer patients.Human cytomegalovirus elicits fetal gammadelta T cell responses in uteroAnti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia modelAdoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells.Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.Characterization of γδT cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro.Activating and propagating polyclonal gamma delta T cells with broad specificity for malignanciesγδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.Clinical applications of gamma delta T cells with multivalent immunity.Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection.Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma.Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development.Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune UveitisHyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus.Vaccination with immunotherapeutic Listeria monocytogenes induces IL-17(+) γδ T cells in a murine model for HPV associated cancer.A new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cellsZoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.IL-23 receptor expression on γδ T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis.Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.Vav1-phospholipase C-γ1 (Vav1-PLC-γ1) pathway initiated by T cell antigen receptor (TCRγδ) activation is required to overcome inhibition by ubiquitin ligase Cbl-b during γδT cell cytotoxicity.Enhanced development of CD4+ gammadelta T cells in the absence of Itk results in elevated IgE production.TCRγ4δ1-engineered αβT cells exhibit effective antitumor activityPersistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.γδ T cells and their potential for immunotherapy.
P2860
Q26782520-5C07046C-8FC3-45AC-8E83-87E92C6E84B7Q26994963-C9E78E14-F38D-4D96-B23F-AC6BAE7C839CQ27026152-3392B1A4-5644-439B-8756-9164581F5052Q27027547-917E8AAE-1747-4D54-8AD8-924BC9E58A06Q28068988-0B37E908-476F-486E-9255-6921E4EE8114Q28659468-6C50922F-A09B-46E1-AB7E-4FE33A1DC294Q30352587-C72B7914-C65C-44B9-9A79-C4FF619B4675Q33322644-CAEAFE0B-E198-4921-9712-01632009F580Q33436859-E5C90E6A-E247-437B-9427-B9917AA41763Q33577355-DB03090F-2821-4F64-949D-EC305674AD95Q33611528-F9F1D62B-101F-4B51-9047-F01EAE2A0CC4Q33795023-BF49F7FC-2211-432C-9DAD-ABA5ED224F51Q33815423-D77D672A-1900-41FD-90C4-48A792D1FE83Q33905819-67E51441-7D9A-4715-A2A7-F26042866BCBQ34277485-6FD6D2DE-4586-42F3-B6FF-96619E159E80Q34426965-0B9C414E-4E43-42B1-A32A-1CFFA22371E3Q34512478-1A604ACA-9CEB-4121-B1EF-E5310C0AB18FQ34517192-452828BB-E400-470C-8834-309DDA74A0E0Q34612619-24E9FDE8-9345-42AE-92AC-8CC1D479C724Q34677859-C6A7A22F-15A0-4D8D-8787-B1383A75AEACQ34681370-6DE3EF2C-5C48-429D-8258-DF48AA3F3096Q34866687-EA248B63-4586-40BD-B290-5D648C79C657Q34983200-EE5F9F1A-2243-48B7-8D46-D56BFD3BACBDQ35208161-28BCB005-6B66-43A1-917F-760CA9BEE5B7Q35587132-71E8AA73-5D2E-4984-82AB-696A9367828EQ35684372-739223BE-7229-4137-98B2-49DBF0934BCAQ35883004-74A3744A-F76E-436E-9139-9DF51F7C1D29Q35937473-6DD094F4-F026-4330-8487-85FEAC3751C5Q36099417-25ECC57E-F5D8-4268-AD8B-F7232944F03CQ36373342-7565A7A9-974F-42FD-BDF0-B32B20394384Q36674426-742AFBBE-0683-4B7D-AA27-FF3CCF9B5218Q36803818-6FD19F3F-D7AE-4E14-83B6-A37A9875E0FBQ37038620-2D19CE77-AE33-42C4-A7C1-DB19094243D0Q37056096-E91535BD-EA8E-4315-BF11-80CC03CF415EQ37127038-579BF602-5564-4914-B114-6E0B8CAED2D9Q37168337-27E2F332-8FC1-4CEF-BAB7-6ABC380095D3Q37268943-D76810D3-AF12-4A78-ADB1-803D3AAEEAF1Q37370559-352CC657-FC83-4EDE-A6BE-E5C4AEBDB921Q37418812-3B306020-7F5E-485F-ADB7-CA6298CE8710Q37576001-3997A6F4-E544-4150-9884-CFB9B3ACB601
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Perspectives of gammadelta T cells in tumor immunology.
@ast
Perspectives of gammadelta T cells in tumor immunology.
@en
type
label
Perspectives of gammadelta T cells in tumor immunology.
@ast
Perspectives of gammadelta T cells in tumor immunology.
@en
prefLabel
Perspectives of gammadelta T cells in tumor immunology.
@ast
Perspectives of gammadelta T cells in tumor immunology.
@en
P2093
P1433
P1476
Perspectives of gammadelta T cells in tumor immunology.
@en
P2093
Daniela Wesch
Dieter Kabelitz
P356
10.1158/0008-5472.CAN-06-3069
P407
P577
2007-01-01T00:00:00Z